Susquehanna International Group, LLP Spring Works Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 114,815 shares of SWTX stock, worth $4.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,815
Previous 142,717
19.55%
Holding current value
$4.17 Million
Previous $5.38 Million
31.58%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$204 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$140 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$128 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$124 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.27B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...